IP Library › Granted Patent US 7,514,538
Granted Patent B2
US 7,514,538 · App. 12/031,612 · Granted Apr 7, 2009

Compositions and methods for the diagnosis and treatment of tumor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,514,538
App. No.
12/031,612
Granted
Apr 7, 2009
Kind
B2
Abstract

The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.

Claims (14)

1. An isolated antibody which binds specifically to the polypeptide of SEQ ID NO:3.

2. The antibody of claim 1 which is a monoclonal antibody.

3. The antibody of claim 1 which is an antibody fragment that binds specifically to the polypeptide of SEQ ID NO: 3.

4. The antibody of claim 1 which is a chimeric or a humanized antibody.

5. The antibody of claim 1 which is conjugated to a growth inhibitory agent.

6. The antibody of claim 1 which is conjugated to a cytotoxic agent.

7. The antibody of claim 6 , wherein the cytotoxic agent is selected from the group consisting of toxins, antibodies, radioactive isotopes and nucleolytic enzymes.

8. The antibody of claim 6 , wherein the cytotoxic agent is a toxin.

9. The antibody of claim 8 , wherein the toxin is selected from the group consisting of maytansinoid and calicheamicin.

10. The antibody of claim 8 , wherein the toxin is a maytansinoid.

11. The antibody of claim 1 which is produced in bacteria.

12. The antibody of claim 1 which is produced in CHO cells.

13. The antibody of claim 1 which induces death of a cell to which it binds.

14. The antibody of claim 1 which is detectably labeled.